According to Cognitive Market Research, the global mevalonic acid market size was USD 512.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 204.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 153.66 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 117.81 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 25.61 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 10.24 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.
The L-mevalonic acid category is the fastest growing segment of the mevalonic acid industry
